Squamous cell carcinoma of the lung secondary prevention: Difference between revisions
(Mahshid) |
|||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Squamous cell carcinoma of the lung}} | {{Squamous cell carcinoma of the lung}} | ||
{{CMG}}; {{AE}} {{ | {{CMG}}; {{AE}}{{SH}} | ||
==Overview== | |||
The secondary prevention of non-small cell lung cancer is based on the stage of non-small cell lung cancer at diagnosis. Secondary prevention includes chest CT imaging along with a periodic evaluation of alert signs in second-hand smokers or active smokers. | |||
==Secondary Prevention== | |||
Measures for secondary prevention for non-small cell lung cancer depends on the stage of non-small cell lung cancer at diagnosis.<ref name="pmid10824565">{{cite journal |vauthors=Tominaga S |title=[Prevention of lung cancer--primary and secondary prevention] |language=Japanese |journal=Nippon Rinsho |volume=58 |issue=5 |pages=1149–52 |year=2000 |pmid=10824565 |doi= |url=}}</ref><ref name="NCI">National Cancer Institute: PDQ® Lung Cancer Prevention. Bethesda, MD: National Cancer Institute. Date last modified 02/16/2016. Available at: http://www.cancer.gov/types/lung/hp/lung-prevention-pdq. Accessed </ref><ref name="pmid21263260">{{cite journal |vauthors=Van't Westeinde SC, van Klaveren RJ |title=Screening and early detection of lung cancer |journal=Cancer J |volume=17 |issue=1 |pages=3–10 |year=2011 |pmid=21263260 |doi=10.1097/PPO.0b013e3182099319 |url=}}</ref> | |||
*The National Comprehensive Cancer Network (NCCN) recommends the following: | |||
**Low-dose helical [[computed tomography]] (CT) scanning is the standard screening modality for early detection. | |||
**Annual screening (patients with high-risk), early detection is discontinued if patients have been 15 years without smoking. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Latest revision as of 16:44, 26 April 2018
Squamous Cell Carcinoma of the Lung Microchapters |
Differentiating Squamous Cell Carcinoma of the Lung from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Squamous cell carcinoma of the lung secondary prevention On the Web |
American Roentgen Ray Society Images of Squamous cell carcinoma of the lung secondary prevention |
FDA on Squamous cell carcinoma of the lung secondary prevention |
CDC on Squamous cell carcinoma of the lung secondary prevention |
Squamous cell carcinoma of the lung secondary prevention in the news |
Blogs on Squamous cell carcinoma of the lung secondary prevention |
Directions to Hospitals Treating Squamous cell carcinoma of the lung |
Risk calculators and risk factors for Squamous cell carcinoma of the lung secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2]
Overview
The secondary prevention of non-small cell lung cancer is based on the stage of non-small cell lung cancer at diagnosis. Secondary prevention includes chest CT imaging along with a periodic evaluation of alert signs in second-hand smokers or active smokers.
Secondary Prevention
Measures for secondary prevention for non-small cell lung cancer depends on the stage of non-small cell lung cancer at diagnosis.[1][2][3]
- The National Comprehensive Cancer Network (NCCN) recommends the following:
- Low-dose helical computed tomography (CT) scanning is the standard screening modality for early detection.
- Annual screening (patients with high-risk), early detection is discontinued if patients have been 15 years without smoking.
References
- ↑ Tominaga S (2000). "[Prevention of lung cancer--primary and secondary prevention]". Nippon Rinsho (in Japanese). 58 (5): 1149–52. PMID 10824565.
- ↑ National Cancer Institute: PDQ® Lung Cancer Prevention. Bethesda, MD: National Cancer Institute. Date last modified 02/16/2016. Available at: http://www.cancer.gov/types/lung/hp/lung-prevention-pdq. Accessed
- ↑ Van't Westeinde SC, van Klaveren RJ (2011). "Screening and early detection of lung cancer". Cancer J. 17 (1): 3–10. doi:10.1097/PPO.0b013e3182099319. PMID 21263260.